Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 1.00 |
| ▸ | SLCO2A1 | Q92959 | 2/20 | 0.74 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.74 |
| ▸ | PTGFR | P43088 | 3/20 | 0.73 |
| ▸ | MEN1 | O00255 | 2/20 | 0.71 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.71 |
| ▸ | TBXA2R | P21731 | 6/20 | 0.66 |
| ▸ | PTGER4 | P35408 | 5/20 | 0.66 |
| ▸ | PTGER1 | P34995 | 4/20 | 0.66 |
| ▸ | PTGER3 | P43115 | 4/20 | 0.66 |
| ▸ | LMNA | P02545 | 4/20 | 0.66 |
| ▸ | PTGDR | Q13258 | 1/20 | 0.66 |
| ▸ | PTGER2 | P43116 | 4/20 | 0.65 |
| ▸ | HPGD | P15428 | 3/20 | 0.65 |
| ▸ | PTGIR | P43119 | 2/20 | 0.65 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.65 |
| ▸ | ESR1 | P03372 | 1/20 | 0.65 |
| ▸ | PGR | P06401 | 1/20 | 0.65 |
| ▸ | TSHR | P16473 | 1/20 | 0.65 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6128402 | 1.00 | ALDH1A1 (1.00) | ALDH1A1SLCO2A1PTGDR2PTGFRMEN1 | |
| SCHEMBL29368985 | 1.00 | ALDH1A1 (1.00) | ALDH1A1SLCO2A1PTGDR2PTGFRMEN1 | |
| SCHEMBL30362666 | 1.00 | ALDH1A1 (1.00) | ALDH1A1SLCO2A1PTGDR2PTGFRMEN1 | |
| SCHEMBL6128403 | 0.90 | ALDH1A1 (0.81) | ALDH1A1SLCO2A1PTGDR2PTGFRMEN1 | |
| SCHEMBL6125190 | 0.90 | ALDH1A1 (0.81) | ALDH1A1SLCO2A1PTGDR2PTGFRMEN1 | |
| SCHEMBL31280569 | 0.87 | ALDH1A1 (0.78) | ALDH1A1SLCO2A1PTGDR2PTGFRMEN1 | |
| SCHEMBL29922049 | 0.87 | ALDH1A1 (0.77) | ALDH1A1SLCO2A1PTGDR2PTGFRMEN1 | |
| SCHEMBL31203308 | 0.87 | ALDH1A1 (0.77) | ALDH1A1SLCO2A1PTGDR2PTGFRMEN1 | |
| [3H]Pgd2 SCHEMBL23352891 | 0.85 | ALDH1A1 (1.00) | ALDH1A1SLCO2A1PTGDR2PTGFRMEN1 | |
| [3H]Pgd2 SCHEMBL13399729 | 0.85 | ALDH1A1 (1.00) | ALDH1A1SLCO2A1PTGDR2PTGFRMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 398 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026106210-A1 | METABOLITE BIOMARKER FOR PREDICTING THERAPEUTIC RESPONSE OF BIOLOGICAL AGENTS IN ASTHMA | 재단법인 아산사회복지재단 | 2026-05-21 | — | — | WO | claimed |
| CN-118255891-B | Kit for detecting urine 11-dehydrothromboxane B2/creatinine and detection method | 北京赛斯维德生物科技有限公司 | 2025-03-11 | — | — | CN | claimed |
| CN-116199767-B | 11-Dehydrothromboxane B2-BSA conjugate, magnetic particle complex, kit and application thereof | 河北艾驰生物科技有限公司 | 2024-12-20 | — | — | CN | claimed |
| EP-4468884-A1 | LYMPH-RELEASING COMPOSITIONS OF FATTY ACIDS AND USES THEREOF FOR LYMPHATIC INCORPORATION AND SYSTEMIC DISEASE TREATMENT | Amarin Pharmaceuticals Ireland Limited (IE) | 2024-12-04 | — | — | EP | claimed |
| WO-2024242465-A1 | LIPID METABOLITE BIOMARKER FOR PREDICTING ASTHMA TREATMENT RESPONSE TO BIOLOGICAL AGENT AND USE THEREOF | 재단법인 아산사회복지재단 | 2024-11-28 | — | — | WO | claimed |
| CN-118837474-A | Application of reagent for detecting serum metabolome in preparation of nasopharyngeal carcinoma diagnosis and/or prognosis products | 江西省肿瘤医院(江西省第二人民医院、江西省癌症中心) | 2024-10-25 | — | — | CN | claimed |
| CN-118714935-A | Lymphoreleased fatty acid compositions and their use for lymphatic incorporation and systemic disease treatment | 阿马里纳药物爱尔兰有限公司 | 2024-09-27 | — | — | CN | claimed |
| CN-118534010-A | Application of metabolic markers in preparation of diabetic retinopathy diagnosis or prognosis products | 海南医学院 | 2024-08-23 | — | — | CN | claimed |
| CN-114324880-B | High-sensitivity 11-dehydrothromboxane B2 detection kit and detection method | 上海云泽生物科技有限公司 | 2024-07-30 | — | — | CN | claimed |
| CN-118255891-A | Kit for detecting urine 11-dehydrothromboxane B2/creatinine and detection method | 北京赛斯维德生物科技有限公司 | 2024-06-28 | — | — | CN | claimed |
| US-6994983-B2 | Kits for determination of thromboxane B2 metabolite and optimizing aspirin dosage | ESOTERIX, INC. COAGULATION (US) | 2006-02-07 | — | — | US | claimed |
| US-6967083-B2 | Thromboxane B2 metabolite methods for optimizing aspirin dosage | ESOTERIX, INC. COAGULATION (US) | 2005-11-22 | — | — | US | claimed |
| WO-2005068442-A2 | ISOXAZOLE DERIVATIVES AND THEIR USE AS CYCLOOXYGENASE INHIBITORS | UNIVERSITA DEGLI STUDI DI BARI (IT) | 2005-07-28 | — | — | WO | claimed |
| US-20040121489-A1 | COX-2 mediated altered prostaglandin balance in diabetes complications | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. | 2004-06-24 | — | — | US | claimed |
| EP-1299719-B1 | CONDUCTIVITY-NORMALIZED URINARY ANALYTE CONCENTRATION MEASUREMENT FOR USE IN DISEASE DIAGNOSIS | BIOPREVENTIVE LTD (IL) | 2004-03-03 | — | — | EP | claimed |
| US-20040015101-A1 | Rapid non-invasive method for differential acute cardiovascular disease diagnosis | ANALYTE WORKS LTD. (IL) | 2004-01-22 | — | — | US | claimed |
| US-20030171698-A1 | Conductivity-normalized urinary analyte concentration measurement for use in disease diagnosis | ANALYTE WORKS LTD. (IL) | 2003-09-11 | — | — | US | claimed |
| US-20030133873-A1 | Thromboxane B2 metabolite and methods for regulating aspirin-related platelet action | ESOTERIX, INC. COAGULATION (US) | 2003-07-17 | — | — | US | claimed |
| US-20030124615-A1 | Thromoboxane B2 metabolite and methods for regulating aspirin-related platelet action | ESOTERIX, INC. COAGULATION | 2003-07-03 | — | — | US | claimed |
| WO-2001031052-A1 | THROMBOXANE B2 METABOLITE AND METHODS FOR REGULATING ASPIRIN-RELATED PLATELET ACTION | COLORADO COAGULATION CONSULTANTS (US) | 2001-05-03 | — | — | WO | claimed |